This is a clinical-stage biopharmaceutical company specialising in oncology. Two of their lead products, NVL-520 and NVL-655, aim to overcome challenges in treatment resistance and issues related to the central nervous system and brain metastases.
This is a clinical-stage biopharmaceutical company specialising in oncology. Two of their lead products, NVL-520 and NVL-655, aim to overcome challenges in treatment resistance and issues related to the central nervous system and brain metastases.